Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

被引：69
作者：
Brown, B. Greg [1 ]
Taylor, Allen J. [2 ,3 ]
机构：
[1] Univ Washington, Sch Med, Seattle, WA 98195 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[3] Walter Reed Army Med Ctr, Serv Cardiol, Washington, DC 20307 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 14期
关键词：
D O I：
10.1056/NEJMe0801608
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1504 / 1507
页数：4
相关论文
共 17 条
  • [1] LIPID DEPLETION IN ATHEROMATOUS CORONARY-ARTERIES IN RHESUS-MONKEYS AFTER REGRESSION DIETS
    ARMSTRONG, ML
    MEGAN, MB
    [J]. CIRCULATION RESEARCH, 1972, 30 (06) : 675 - +
  • [2] Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
    Bots, Michiel L.
    Visseren, Frank L.
    Evans, Gregory W.
    Riley, Ward A.
    Revkin, James H.
    Tegeler, Charles H.
    Shear, Charles L.
    Duggan, William T.
    Vicari, Ralph M.
    Grobbee, Diederick E.
    Kastelein, John J.
    [J]. LANCET, 2007, 370 (9582) : 153 - 160
  • [3] Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?
    Bots, Michiel L.
    Baldassarre, Damiano
    Simon, Alain
    de Groot, Eric
    O'Leary, Daniel H.
    Riley, Ward
    Kastelein, John J.
    Grobbee, Diederick E.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 (04) : 398 - 406
  • [4] Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials
    Brown, B. Greg
    Stukovsky, Karen Hinckley
    Zhao, Xue-Qiao
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (06) : 631 - 636
  • [5] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
    Brown, BG
    Zhao, XQ
    Chait, A
    Fisher, LD
    Cheung, MC
    Morse, JS
    Dowdy, AA
    Marino, EK
    Bolson, EL
    Alaupovic, P
    Frohlich, J
    Albers, JJ
    Serafini, L
    Huss-Frechette, E
    Wang, S
    DeAngelis, D
    Dodek, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) : 1583 - 1592
  • [6] LIPID-LOWERING AND PLAQUE REGRESSION - NEW INSIGHTS INTO PREVENTION OF PLAQUE DISRUPTION AND CLINICAL EVENTS IN CORONARY-DISEASE
    BROWN, BG
    ZHAO, XQ
    SACCO, DE
    ALBERS, JJ
    [J]. CIRCULATION, 1993, 87 (06) : 1781 - 1791
  • [7] Design and rationale of the ARBITER 6 trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL treatment strategies in atherosclerosis (HALTS)
    Devine, Patrick J.
    Turco, Mark A.
    Taylor, Allen J.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 (03) : 221 - 225
  • [8] Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe
    During, Alexandrine
    Dawson, Harry D.
    Harrison, Earl H.
    [J]. JOURNAL OF NUTRITION, 2005, 135 (10) : 2305 - 2312
  • [9] Relation of plaque lipid composition and morphology to the stability of human aortic plaques
    Felton, CV
    Crook, D
    Davies, MJ
    Oliver, MF
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (07) : 1337 - 1345
  • [10] Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD:: clinical evidence for 'pleiotropic' functions of statin therapy
    Fichtlscherer, S
    Schmidt-Lucke, C
    Bojunga, S
    Rössig, L
    Heeschen, C
    Dimmeler, S
    Zeiher, AM
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (10) : 1182 - 1190
12